Harpoon Therapeutics, Inc.
NASDAQ:HARP
23.01 (USD) • At close March 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 51.614 | 44.687 | 21.17 | 155.129 | 89.493 | 29.423 | 0.985 |
Short Term Investments
| 1.498 | 90.411 | 104.86 | 59.337 | 0 | 0 | 0 |
Cash and Short Term Investments
| 53.112 | 135.098 | 149.976 | 155.129 | 89.493 | 29.423 | 0.985 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 6.75 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 1.615 | 2.597 | 3.724 | 2.544 | 0.73 | 0.224 | 0.559 |
Total Current Assets
| 54.727 | 137.695 | 129.754 | 150.617 | 90.223 | 29.647 | 8.294 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 18.091 | 15.375 | 16.771 | 18.398 | 2.998 | 2.087 | 0.09 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0.673 | 1.522 | 23.946 | 7.056 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.238 | 0.86 | 1.121 | 0.533 | 9.359 | 0.138 | 0 |
Total Non-Current Assets
| 19.002 | 17.757 | 41.838 | 25.987 | 12.357 | 2.225 | 0.09 |
Total Assets
| 73.729 | 155.452 | 171.592 | 176.604 | 102.58 | 31.872 | 8.384 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 4.712 | 2.666 | 1.572 | 2.594 | 4.357 | 1.174 | 0.281 |
Short Term Debt
| 2.423 | 1.649 | 1.202 | 1.217 | 0 | 0 | 2.312 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 30.937 | 37.462 | 31.299 | 11.207 | 4.25 | 4.25 | -2.312 |
Other Current Liabilities
| 14.361 | 17.362 | 13.845 | 7.495 | 3.341 | 1.492 | 3.581 |
Total Current Liabilities
| 52.433 | 59.139 | 47.918 | 22.513 | 11.948 | 6.916 | 3.862 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 13.583 | 10.538 | 12.313 | 13.727 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 2.314 | 27.705 | 57.522 | 46.144 | 7.792 | 12.042 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 136.319 | 39.857 | 14.966 |
Total Non-Current Liabilities
| 15.897 | 38.243 | 69.835 | 59.871 | 144.111 | 51.899 | 14.966 |
Total Liabilities
| 68.33 | 97.382 | 117.753 | 82.384 | 156.059 | 58.815 | 18.828 |
Equity: | |||||||
Preferred Stock
| 0 | 155.452 | 171.592 | 176.604 | 129.577 | 0 | 0 |
Common Stock
| 0.004 | 0.004 | 0.003 | 0.003 | 0.001 | 0.001 | 0.001 |
Retained Earnings
| -352.523 | -284.792 | -168.071 | -118.163 | -62.591 | -35.225 | -18.395 |
Accumulated Other Comprehensive Income/Loss
| -0.003 | -0.047 | 0.003 | 0.041 | -1.014 | -0.37 | -0.024 |
Other Total Stockholders Equity
| 357.921 | 187.453 | 50.312 | 35.735 | -119.452 | 8.651 | 7.974 |
Total Shareholders Equity
| 5.399 | 58.07 | 53.839 | 94.22 | -53.479 | -26.943 | -10.444 |
Total Equity
| 5.399 | 58.07 | 53.839 | 94.22 | -53.479 | -26.943 | -10.444 |
Total Liabilities & Shareholders Equity
| 73.729 | 155.452 | 171.592 | 176.604 | 102.58 | 31.872 | 8.384 |